Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Augustin

Showing results (411-420 of 491) with videos related to

Pageof 50
Sort By:
BMJ Open|February 15, 2023
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)Matthias Augustin, Rachel Sommer, Esteban Daudén, et al.
JAAD International|December 2, 2024
Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)Dagmar Wilsmann-Theis, Selina Patt, Andreas Pinter, et al.
International Wound Journal|December 4, 2023
Validation of the Wound-QoL-17 and the Wound-QoL-14 in a European sample of 305 patients with chronic woundsToni Maria Janke, Vlastimil Kozon, Skaidra Valiukeviciene, et al.
Plos One|September 12, 2013
Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skinNatalia T Meier, Iain S Haslam, David M Pattwell, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 11, 2024
The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in GermanyMatthias Augustin, Dominik Beier, Jennifer Branner, et al.
Acta Dermato-Venereologica|June 11, 2016
Psoriasis - The Life Course ApproachMichael Dennis Linder, Stefano Piaserico, Matthias Augustin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 26, 2010
Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab"Alexander Nast, Matthias Augustin, Wolf-Henning Boehncke, et al.
Plos One|April 9, 2024
Spatial characteristics of non-communicable diseases and their associations to social conditions in a large urban cohort in Germany-Results from the Hamburg City Health StudyValerie Andrees, Ramona Bei der Kellen, Matthias Augustin, et al.
Acta Dermato-Venereologica|May 18, 2019
Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional StudyFlorian Anzengruber, Matthias Augustin, Marc A Radtke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 1, 2023
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registriesMatthias Augustin, Lisa Lindner, Laura Kühl, et al.
Pageof 50

Showing results (411-420 of 491) with videos related to

Sort By:
Pageof 50
BMJ Open|February 15, 2023
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)Matthias Augustin, Rachel Sommer, Esteban Daudén, et al.
JAAD International|December 2, 2024
Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study)Dagmar Wilsmann-Theis, Selina Patt, Andreas Pinter, et al.
International Wound Journal|December 4, 2023
Validation of the Wound-QoL-17 and the Wound-QoL-14 in a European sample of 305 patients with chronic woundsToni Maria Janke, Vlastimil Kozon, Skaidra Valiukeviciene, et al.
Plos One|September 12, 2013
Thyrotropin-releasing hormone (TRH) promotes wound re-epithelialisation in frog and human skinNatalia T Meier, Iain S Haslam, David M Pattwell, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 11, 2024
The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in GermanyMatthias Augustin, Dominik Beier, Jennifer Branner, et al.
Acta Dermato-Venereologica|June 11, 2016
Psoriasis - The Life Course ApproachMichael Dennis Linder, Stefano Piaserico, Matthias Augustin, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 26, 2010
Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab"Alexander Nast, Matthias Augustin, Wolf-Henning Boehncke, et al.
Plos One|April 9, 2024
Spatial characteristics of non-communicable diseases and their associations to social conditions in a large urban cohort in Germany-Results from the Hamburg City Health StudyValerie Andrees, Ramona Bei der Kellen, Matthias Augustin, et al.
Acta Dermato-Venereologica|May 18, 2019
Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional StudyFlorian Anzengruber, Matthias Augustin, Marc A Radtke, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 1, 2023
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registriesMatthias Augustin, Lisa Lindner, Laura Kühl, et al.
Pageof 50